Winning Health Technology Group Past Earnings Performance
Past criteria checks 3/6
Winning Health Technology Group's earnings have been declining at an average annual rate of -11.5%, while the Healthcare Services industry saw earnings declining at 6.9% annually. Revenues have been growing at an average rate of 14.6% per year. Winning Health Technology Group's return on equity is 7.2%, and it has net margins of 13.7%.
Key information
-11.5%
Earnings growth rate
-12.0%
EPS growth rate
| Healthcare Services Industry Growth | 14.5% |
| Revenue growth rate | 14.6% |
| Return on equity | 7.2% |
| Net Margin | 13.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Winning Health Technology Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,209 | 438 | 722 | 309 |
| 31 Dec 23 | 3,163 | 358 | 794 | 333 |
| 30 Sep 23 | 3,123 | 121 | 905 | 325 |
| 30 Jun 23 | 3,189 | 58 | 1,031 | 360 |
| 31 Mar 23 | 3,097 | 13 | 995 | 342 |
| 01 Jan 23 | 3,093 | 109 | 942 | 314 |
| 30 Sep 22 | 2,858 | 258 | 861 | 294 |
| 30 Jun 22 | 2,822 | 333 | 825 | 261 |
| 31 Mar 22 | 2,851 | 396 | 810 | 259 |
| 01 Jan 22 | 2,750 | 378 | 819 | 256 |
| 30 Sep 21 | 2,658 | 547 | 661 | 242 |
| 30 Jun 21 | 2,498 | 528 | 677 | 244 |
| 31 Mar 21 | 2,333 | 494 | 635 | 243 |
| 31 Dec 20 | 2,267 | 491 | 599 | 229 |
| 30 Sep 20 | 2,082 | 329 | 549 | 227 |
| 30 Jun 20 | 2,032 | 311 | 527 | 221 |
| 31 Mar 20 | 1,939 | 353 | 481 | 216 |
| 31 Dec 19 | 1,908 | 398 | 464 | 206 |
| 30 Sep 19 | 1,712 | 384 | 415 | 190 |
| 30 Jun 19 | 1,561 | 347 | 367 | 176 |
| 31 Mar 19 | 1,480 | 320 | 327 | 158 |
| 31 Dec 18 | 1,439 | 303 | 319 | 147 |
| 30 Sep 18 | 1,439 | 288 | 353 | 130 |
| 30 Jun 18 | 1,330 | 259 | 309 | 171 |
| 31 Mar 18 | 1,242 | 243 | 301 | 138 |
| 31 Dec 17 | 1,204 | 229 | 320 | 110 |
| 30 Sep 17 | 1,059 | 193 | 316 | 77 |
| 30 Jun 17 | 1,011 | 184 | 380 | 0 |
| 31 Mar 17 | 987 | 523 | 373 | 0 |
| 31 Dec 16 | 954 | 519 | 360 | 0 |
| 30 Sep 16 | 901 | 522 | 337 | 0 |
| 30 Jun 16 | 852 | 517 | 326 | 0 |
| 31 Mar 16 | 791 | 158 | 321 | 0 |
| 31 Dec 15 | 753 | 153 | 296 | 0 |
| 30 Sep 15 | 647 | 142 | 256 | 0 |
| 30 Jun 15 | 607 | 142 | 215 | 0 |
| 31 Mar 15 | 536 | 127 | 201 | 0 |
| 31 Dec 14 | 491 | 121 | 180 | 0 |
| 30 Sep 14 | 402 | 100 | 157 | 0 |
| 30 Jun 14 | 374 | 91 | 155 | 0 |
| 31 Mar 14 | 358 | 84 | 140 | 0 |
| 31 Dec 13 | 349 | 81 | 140 | 0 |
| 30 Sep 13 | 325 | 68 | 131 | 0 |
| 30 Jun 13 | 297 | 61 | 128 | 0 |
Quality Earnings: 300253 has a large one-off gain of CN¥94.9M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 300253's current net profit margins (13.7%) are higher than last year (0.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300253's earnings have declined by 11.5% per year over the past 5 years.
Accelerating Growth: 300253's earnings growth over the past year (3183.7%) exceeds its 5-year average (-11.5% per year).
Earnings vs Industry: 300253 earnings growth over the past year (3183.7%) exceeded the Healthcare Services industry 3.2%.
Return on Equity
High ROE: 300253's Return on Equity (7.2%) is considered low.